Filing Flows › EBR Systems (NONE.) › Recalls, complaints & regulation
EBR Systems (NONE.): clinical trials
EBR Systems (NONE.) beyond its filings: 4 active clinical trials.
EBR Systems' latest quarter
EBR Systems, Q2 2026: revenue $2.6M (16× year over year), operating margin -621.8%, net loss $17.5M, operating cash flow −$17.2M. The chart follows the revenue to costs, profit and cash.
Questions
How many clinical trials does EBR Systems have?
4 active studies on ClinicalTrials.gov, 0 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.